Pancreatic carcinoma cell lines stably expressing the CEACAM6 shRNA and yCDglyTK gene were then established and anti-tumor efficacy of the recombinant plasmid was evaluated in vitro. This evidence concerns the gene CEACAM6 and neoplasm.